Non-small cell lung cancer (NSCLC) Clinical Trials in Fremont, NE
As of July 2026, 1 paid clinical trial is recruiting for Non-small cell lung cancer (NSCLC) in Fremont, Nebraska. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Fremont
Filter results
1 clinical trial for Non-small cell lung cancer (NSCLC)
·Clear filters·Top Research Study Locations in Fremont
Researchers run research studies in Fremont, NE at 4 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Methodist Physicians Clinic | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Oncology Hematology West, PC dba Nebraska Cancer Specialists - Fremont | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| Research | Hypertriglyceridemia | 1 |
Active & Upcoming Studies in Fremont (2026)
Recruiting trials in Fremont grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (2 active studies)
- Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus · Phase 2 · Hanmi Pharmaceutical Company Limited
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Cardiovascular (2 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Cancer & tumors (1 active study)
Common conditions studied in Fremont
- Hypertension (2 active studies)
- COPD (Chronic Obstructive Pulmonary Disease) (1 active study)
- Carcinoma, Non-Small-Cell Lung (1 active study)
- Carcinoma, Non-Small-Cell Lung (NSCLC) (1 active study)
- Cardiovascular Disease (1 active study)
- Cardiovascular Diseases (1 active study)
Leading research sponsors in Fremont
- AstraZeneca
- Alnylam Pharmaceuticals
- Arrowhead Pharmaceuticals
- Boehringer Ingelheim
- Hanmi Pharmaceutical Company Limited
Frequently asked questions
How many paid clinical trials are currently recruiting in Fremont?
There are approximately 7 recruiting clinical trials in Fremont, Nebraska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fremont pay participants?
Most recruiting trials in Fremont compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fremont?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fremont?
The most common conditions under active study in Fremont include Hypertension (2), COPD (Chronic Obstructive Pulmonary Disease) (1), Carcinoma, Non-Small-Cell Lung (1), Carcinoma, Non-Small-Cell Lung (NSCLC) (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fremont?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fremont on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fremont?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fremont?
Recruiting research sites in Fremont include Methodist Physicians Clinic, Clinical Trial Site, Oncology Hematology West, PC dba Nebraska Cancer Specialists - Fremont, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fremont right now?
The largest active categories in Fremont are Diabetes & metabolic (2), Cardiovascular (2), Cancer & tumors (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.